Details of the Drug

General Information of Drug (ID: DM46QU4)

Drug Name

Birtamimab

Synonyms

NEOD001

Indication

Disease Entry	ICD 11	Status	REF
Al amyloidosis	5D00.0	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Monoclonal antibody

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04973137) A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Placebo Plus Standard of Care in Mayo Stage IV Subjects With Light Chain (AL) Amyloidosis. U.S.National Institutes of Health.